← FDA Drug Approvals (Drugs@FDA)

BORTEZOMIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JIANGSU HANSOH PHARM · Approved 2022-07-26

Drug application

FDA Application #

ANDA215011

Application type

Abbreviated New Drug Application (Generic)

Brand name

BORTEZOMIB

Generic name

BORTEZOMIB

Active ingredients

BORTEZOMIB

Dosage form

INJECTABLE

Route

INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

JIANGSU HANSOH PHARM

Manufacturer

Hikma Pharmaceuticals USA Inc.

First approval

2022-07-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown